ABCG2 (also known as the breast cancer resistance protein – BCRP) plays a pivotal role in drug resistance (e.g. anthracyclines and topoisomerase inhibitors) and as important marker of side population cells, which are enriched for cells with CSC characteristics in breast cancer [27, 28]. The gene discussed is ABCG2; the disease is breast carcinoma.